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in the lateral dermomyotome contribute to the ventral75724 Paris, Cedex 15
aspect of the myotome, which will form the hypaxialFrance
(e.g., abdominal and body wall) muscles of the body²Department of Histology and Medical Embryology
(Christ and Ordahl, 1995). At the limb levels, cells des-University of Rome, La Sapienza
tined to form skeletal muscle migrate from the lateral00161 Rome
dermomyotome into the limb field. At this stage they doItaly
not express any myogenic regulatory factors (MRFs) or
other skeletal muscle markers (Sassoon et al., 1989;
Tajbakhsh and Buckingham, 1994).Summary
The basic±helix-loop-helix (bHLH) MRFs Myf-5, MyoD,
myogenin, and MRF4 act as transcriptional activatorsWe analyzed Pax-3 (splotch), Myf-5 (targeted with
of skeletal muscle genes, and their forced expression innlacZ), and splotch/Myf-5 homozygous mutant mice
many nonmuscle cell types induces the skeletal muscleto investigate the roles that these genes play in pro-
differentiation program (reviewed by Weintraub et al.,gramming skeletal myogenesis. In splotch and Myf-5
1991). Gene knockout experiments have shown that al-homozygous embryos, myogenic progenitor cell per-
though Myf-5 null (Braun et al., 1992) or MyoD null (Rud-turbations and early muscle defects are distinct. Re-
nicki et al., 1992) mice make muscle, Myf-5/MyoD dou-markably, splotch/Myf-5 double homozygotes have a
ble mutants are devoid of muscle fibers and myoblastsdramatic phenotype not seen in the individual mutants:
(Rudnicki et al., 1993). myogenin null mice have virtuallybody muscles are absent. MyoD does not rescue this
no muscle fibers but myoblasts appear normal (Hastydouble mutant phenotype since activation of this gene
et al., 1993; Nabeshima et al., 1993), suggesting that thisproves to be dependent on either Pax-3 or Myf-5.
gene is necessary for terminal differentiation, whereasTherefore, Pax-3 and Myf-5 define two distinct myo-
MRF4 null mice have no prominent muscle defects (re-genic pathways, and MyoD acts genetically down-
viewed by Olson et al., 1996). It is therefore believed
stream of these genes for myogenesis in the body.
that Myf-5 and MyoD can compensate for each other
This genetic hierarchy does not appear to operate for
and together act in a genetic pathway upstream of myo-head muscle formation.
genin and MRF4 to program all skeletal myogenesis. In
the mouse, Myf-5 is the first MRF to be expressed in
Introduction the somite (Ott et al., 1991; Buckingham, 1992), prior
to myotome formation and about 2 days before MyoD
During vertebrate embryogenesis, paraxial mesoderm activation. During this developmental period, muscle
flanking the neural tube becomes segmented into epi- progenitor cells that have activated Myf-5 remain
thelial spheres called somites, which subsequently be- multipotent and can change their fate in the absence of
come compartmentalized into a dorsal epithelial dermo- Myf-5 protein. This occurs as a result of an aberrant
myotome (muscle and dermis) and a ventral mesenchymal migration and mislocalization of these cells in Myf-5 null
sclerotome (vertebral columnand ribs). Myogenic progen- embryos (Tajbakhsh et al., 1996b). In explant experi-
itor cells in the dermomyotome give rise to all of the ments, Myf-5 is the first MRF gene to be induced by axial
skeletal muscles of the body (trunk and limb) and some structures, which correlates with its early expression in
head muscles, while the remaining head muscles arise the dorsomedial part of the somite adjacent to the neural
from more anterior nonsomitic paraxial and prechordal tube, whereas MyoDappears to be induced more rapidly
head mesoderm (reviewed by Wachtler and Christ, 1992; in response to dorsal ectoderm. Subsequently, Myf-5
Christ and Ordahl, 1995). and MyoD are coexpressed in the majority of cells with
Manipulations in avian embryos have shown that cells myogenic potential both in vitro and in the embryo
in the epithelial somite are multipotent and will adopt (Cossu et al., 1996a; Tajbakhsh et al., 1996a).
a particular somitic fate according to their position in Pax-3, a mammalian homolog of the Drosophila paired
relation to surrounding structures (Christ and Ordahl, gene, encodes a transcription factor and belongs to a
1995). This conclusion is also supported by explant ex- family of developmentally regulated genes (Strachan
periments with early somites and presomitic mesoderm and Read, 1994). In the mouse, Pax-3 and the closely
(reviewed by Cossu et al., 1996b). Activation of myogen- related paired box gene Pax-7 are expressed in meso-
esis in medially located muscle progenitor cells in the dermal and neuroectodermal derivatives. Mice hetero-
dermomyotome depends on axial structures (neural zygous for mutations in Pax-3 (splotch [Sp]) are charac-
tube and notochord) leading to myotome formation in terized by pigmentation defects due to perturbations in
the central aspect of the somite. Cells in this (dorsal) neural crest migration, whereas homozygous embryos
have a number of neural defects, including spina bifidadomain of the myotome subsequently form the epaxial
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and exencephaly (reviewed by Tremblay and Gruss,
1994). Most homozygous mutant Sp alleles are lethal
prior to embryonic day 15 (E15). Pax-3 is expressed in
the unsegmented paraxial mesoderm (UPM) and epithe-
lial somite, becoming confined first to the dermomyo-
tome and later to its lateral half. Cells that migrate from
the lateral part of the somite to the limb express Pax-3
(Williams and Ordahl, 1994; Daston et al., 1996). Indeed,
Sp mice lack limb muscles, demonstrating that Pax-3
is necessary for the migration of this muscle precursor
cell population (Bober et al., 1994; Goulding et al., 1994;
Marcelle et al., 1995). This phenotype is similar to that
of mice carrying a null mutation in the met receptor gene
(Bladt et al., 1995; Maina et al., 1996), and recent results
suggest that Pax-3 may directly activate the met gene
(Epstein et al., 1996; Yang et al., 1996). The latter is also
expressed in the dermomyotome, and muscle precursor
cells expressing met may migrate in response to its
ligand, scatter factor, which is present in the proximal
limb (Bladt et al., 1995).
Since Pax-3 and Myf-5 are expressed in muscle pro-
genitor cells, we analyzed loss-of-function mutations in
single and doublemutant mice to investigate the respec-
tive roles that the Pax-3 and Myf-5 genes play in pro-
gramming myogenesis. While the individual mutations
display perturbations in some distinct skeletal muscles,
strikingly, in Sp/Myf-5 double homozygous mutant em-
bryos, skeletal muscles in the body are ablated. In the
absence of Pax-3and Myf-5,MyoD is not activated in the
body and therefore cannot rescue skeletal myogenesis,
suggesting that it acts genetically downstream from
Pax-3 and Myf-5. Moreover, neither Pax-3 nor Pax-7 is
Figure 1. Skeletal Muscle Perturbations Are Distinct in Sp and Myf-detectable in skeletal muscle progenitors of the head,
5a22/2 Homozygous Mutant Embryossuggesting that myogenic regulatory circuits in the head
E12.5 embryos were analyzed by X-Gal staining in toto.and body are distinct.
(A) Myf-5a21/2 embryo. The forming latissimusdorsi muscle (asterisk),
deep back (arrow), and intercostal (double arrows) muscles are indi-
cated.
Results (B) Myf-5a22/2 embryo showing deep back (arrow) and shoulder mus-
cle perturbations. Notably, a shoulder muscle group opposite and
anterior to the forelimb (arrowheads), which activates MyoD rela-Migrating Muscle Populations Are Absent
tively early, is less perturbed.in Sp Mice
(C) Sp/Myf-5a21/2 embryo with deep back muscle perturbationsWe crossed Sp with Myf-5/nlacZ (Myf-5a21/2) heterozy-
(arrow) distinct from those in the Myf-5a22/2 embryo. Intercostal mus-
gous mice to facilitate the analysis of skeletal muscle cles appear properly segmented but have a shortening and disorga-
perturbations and patterning in the absence of Pax-3. nization of their most ventral extent (double arrows).
As expected, limb muscles were missing in Sp/Myf- (D) Sp/Myf-5a22/2 embryo showing b-gal1 cells in a segmented orga-
nization extending dorsally. A few b-gal1 cells are also seen in the5a21/2 embryos (Figure 1C). However, other skeletal mus-
hindlimb (arrowhead). Lack of limb muscles and spina bifida in thecle perturbations were also detected. The latissimus
caudal neural tube (failure to close) distinguish the Sp mutants.dorsi muscle, originating just posterior to the forelimb
and later spanning dorsoventrally in the interlimb region,
is absent in Sp homozygous embryos (Figures 1A, 1C, largely absent inSp homozygous embryos. It isnotewor-
thy that some deep back muscles derived from the me-2A, and 2B). Muscles of the shoulder, ventral body, and
diaphragm (Figure 2F) also were missing. In addition, dial-half somite were also noticeably absent in Sp/Myf-
5a21/2 embryos by E12.5 (Figure 1C).from about embryonic day 10 (E10), muscle progenitor
cells originating from the occipital somites undergo a
long-range migration underneath the arches to consti- Skeletal Muscle Perturbations Are Distinct
in Sp Homozygous and Myf-5 Null Micetute the hypoglossal muscles of the throat and some
tongue musculature. These cells, which activate Pax-3 Myf-5 null mice carrying the bacterial nlacZ reporter
gene under the control of Myf-5 regulatory sequencesinitially and subsequently express Myf-5, MyoD, and
myogenin, were absent in Sp homozygous embryos at (Tajbakhsh et al., 1996b) reproduce the delay in myo-
tome formation, truncated rib phenotype, and perinatalE10.5 (Figures 4C, 4H, and 4L and data not shown).
These findings suggest that migrating muscle progen- death described for another allele at this locus (Braun
et al., 1992). We have shown that nlacZ faithfully recapit-itor cells in the lateral-half somite, which express Pax-3
prior to activation of Myf-5 or MyoD (see below), are ulates Myf-5 expression in these mice (Tajbakhsh and
Pax-3 and Myf-5 Act Upstream of MyoD
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Figure 2. Skeletal Muscles Are Ablated in the Body of Sp/Myf-5a22/2 Double Homozygous Embryos
E14.5 Myf-5a21/2 (A), Sp/Myf-5a21/2 (B), and Sp/Myf-5a22/2 (C with exencephaly, D, and H) embryos were analyzed by X-Gal staining in toto. The
Myf-5a21/2 embryo was stained more briefly with X-Gal to distinguish muscle groups more clearly. The prominent latissimus dorsi muscle (A
and E, asterisk) is missing in Sp embyros (B, C, D, F, and G). Some b-gal1 cells are reproducibly detected in the hindlimb of Sp mutants (C
and D, arrowheads). (E, F, G, and I) In situ hybridizations with an antisense myogenin riboprobe on saggital sections of wild-type (E), Sp/Myf-
5a21/2 (F), and Sp/Myf-5a22/2 (G and I) E14.5 embryos, visualized by dark-field microscopy. Note the absence of diaphragm muscle (double
arrowheads) and some neck and shoulder muscles in embryos mutant for Pax-3 (F and G). In toto X-Gal stained (H) and saggital section
reacted with a myogenin riboprobe (I) of a Sp/Myf-5a22/2 embryo reveals that the metameric b-gal expression, appearing as pink in dark field
(underneath the neck muscles on whole mount), is myogenin negative (arrowheads) while the neck muscles are myogenin positive (arrow). l,
lung; li, liver, h, heart. Scale bar, 150 mm (E±G) and 40 mm (I).
Buckingham, 1995; Tajbakhsh et al., 1996a). The ability Body Muscles Are Ablated in Sp/Myf-5
Double Homozygous Miceto readily monitor b-galactosidase±positive (b-gal1)
cells and muscles by whole-mount coloration permitted To determine which aspects of skeletal muscle develop-
ment are controlled by Pax-3 and Myf-5, we interbredus to detect early skeletal muscle perturbations that
were not reported previously (Braun et al., 1992; Braun double heterozygous Sp/1/Myf-5a21/2 mice to obtain
double homozygous mutants. As expected, Sp and Myf-et al., 1994).
The skeletal muscle defects observed in Sp homozy- 5a22/2 homozygous embryos were not viable. Double het-
erozygous mice were viable and fertile and were usedgotes were qualitatively distinct from those in Myf-5 null
mice (Figures 1B and 1C). Prior to MyoD activation, the as breeding stocks. No obvious skeletal muscle abnor-
malities were seen in these animals.early myotome is absent in Myf-5 null mice, and b-gal1
muscle progenitor cells are disorganized (Tajbakhsh et Strikingly, analysis of double homozygous mutant em-
bryos revealed that nlacZ expression in the body wasal., 1996b; Figure 4B). Subsequently, at E12.5, a stage
when MyoD is normally present (Sassoon et al., 1989), almost entirely eliminated, whereas head muscles were
apparently normal (Figures 1D, 2C, and 2D). To deter-perturbations extending along the anterior±posterior
axis were evident, particularly in the deep back and mine whether this observation does not reflect merely
a down- regulation of the Myf-5 promoter, we analyzeddorsal and ventral interlimb muscles (Figure 1B). Some
of the ventral disorganization in the thoracic region may saggital sections for the presence of transcripts of the
muscle differentiation marker myogenin. In situ hybrid-be due to the truncated rib phenotype. The skeletal
muscle deficiencies observed at early stages in Myf- ization revealed that myogenin expression was absent
in the body of these animals but was present in the head5a22/2 embryos were less prominent after E14.5 (data not
shown). Both Pax-3 and Myf-5 are therefore important (Figure 2G). Examination of fetuses in whole mount and
sections showed that the double mutants have a re-in the establishment of skeletal muscles in the body at
early developmental stages. duced size in the back and body wall regions compared
Cell
130
Figure 3. MyoD and MHC Expression Are
Ablated in the Body of Sp/Myf-5a22/2 Double
Homozygous Embryos
Serial transverse cryostat sections from
X-Gal±stained E12.5 Myf-5a21/2 (A, C, and E)
and Sp/Myf-5a22/2 (B, D, and F) embryos were
reacted either with a fluorescence- labeled
anti-MHC (A and B) or a peroxidase-labeled
anti-MyoD (C±F) antibody. A small group of
cells adjacent to the neural tube is positive
for both markers in the double mutant (B and
D, arrowheads). Arrows (D) indicate aber-
rantly located b-gal1 cells seen more proxi-
mally and dorsally. e, eye; fl, forelimb; h, car-
diac muscle; m, masseter; nt, neural tube; t,
temporalis. Scale bar, 30 mm (A±D) and 15
mm (E and F).
to Sp homozygous or wild-type littermates (Figures 2 as cardiac muscle were positive with this antibody in
E12.5 Myf-5a21/2 embryos, Sp/Myf-5a22/2 doublehomozy-and 3 and data not shown). Occasionally, traces of myo-
genin expression were observed in the body of double gous embryos lacked MHC expression in the trunk and
limbs while labeling in the heart appeared normal (Fig-mutants (data not shown).
Although Myf-5 expression was almost entirely ab- ures 3A and 3B). MyoD protein expression also was
ablated in these double mutants (see below).lated in the body of Sp/Myf-5a22/2 double homozygous
embryos, some b-gal1 regionswere detected reproduci- Therefore, we conclude that skeletal muscles of the
body are ablated in Sp/Myf-5a22/2 double homozygousbly in the body of these mutants (Figures 2C, 2D, and
2H; see also below). A few b-gal1 cells appearing in a embryos while head muscles are present. Given the
latter finding, we examined the expression of Pax-3 andsegmental organization were detected dorsally (Figure
2H), and a group of b-gal1 cells was observed in the Pax-7 in muscle precursors and developing muscles of
the body and head by whole-mount in situ hybridizationproximal region of the hindlimb (Figures 2C and 2D). In
addition, some neck muscles that appear to extend from (Figures 4K±4N and data not shown). Both genes were
expressed in the somites, with Pax-7 in the central der-the head into the body of the embryo were observed in
these double mutants (Figure 2H). To evaluate thenature momyotome (Figure4M) and Pax-3 more laterally (Figure
4K), and both were expressed in skeletal muscles atof these b-gal1 cells in the body, we examined saggital
sections from E14.5 Sp/Myf-5a22/2 embryos that were later stages (data not shown). However, neither Pax-3
norPax-7 transcriptswere detectable in forming skeletalstained for b-gal activity and then hybridized with an
antisense myogenin probe (Figures 2H and 2I). Our anal- muscles or their precursors in the head (Figures 4K and
4M and data not shown). The expression pattern ofysis revealed that b-gal1 cells in the hindlimb and dorsal
body were negative for myogenin, with some of these Pax-7 did not appear to be significantly altered in the
body or head of Sp homozygous embryos (Figure 4Ncells appearing in cartilage (Figure 2I and data not
shown). These observations suggest that they are mislo- and data not shown). Furthermore, Pax-7 is expressed
later than Pax-3, and Pax-7 null mice do not appear tocated muscle progenitor cells, as described in Myf-5
null embryos at early stages (Tajbakhsh et al., 1996b). have a muscle phenotype (Mansouri et al., 1996).
The neck muscles, however, transcribe the myogenin
gene. Distinct Muscle Progenitor Cell Perturbations
in Sp, Myf-5, and Sp/Myf-5 HomozygousTo analyze further this muscle phenotype, we used
an anti±myosin heavy chain (MHC) antibody that recog- Mutant Embryos
To understand the respective roles that Pax-3 andnizes the major striated muscle isoforms of this family.
Whereas skeletal muscles in the trunk and limb as well Myf-5 play in programming myogenesis, we examined
Pax-3 and Myf-5 Act Upstream of MyoD
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Figure 4. Perturbations in Pax-3 and MRF
Expression in Mutant Embryos
E10.5 mutant embryos were analyzed by
X-Gal staining in toto (A±D).
(A) Myf-5a21/2 embryo showing b-gal1 cells in
the forelimb (fl). The dorsal (d) and ventral (v)
domains of the myotome (m) overlap. Muscle
precursors in the hypoglossal chord are indi-
cated (arrowhead), anterior to the heart (h).
Bar indicates first cervical somite, anterior to
which are the occipital somites.
(B) Myf-5a22/2 embryo showing muscle pro-
genitor cell perturbations in all somites, par-
ticularly those in the interlimb region where
epaxial and hypaxial progenitors accumulate
(double arrowheads) along the dorsal (white)
and ventral (black) edges of the somite.
(C) Sp/Myf-5a21/2 embryo showing an ex-
panded pattern of b-gal1 cells ventrally in ad-
jacent somites (double arrows; see also H
and J).
(D) Sp/Myf-5a22/2 embryo showing b-gal1
cells in the ventral domain of interlimb so-
mites are missing (black double arrowheads).
In all embryos, muscle precursors of the
arches (asterisks) are present.
(E and F) Whole-mount in situ hybridizations
using an antisense Pax-3 probe (purple) on
E11.5 unstained (E) and briefly X-Gal±stained
(F, blue) Myf-5a21/2 and Myf-5a22/2 embryos (in-
terlimb region shown). Ventral (v) staining of
Pax-3 corresponds to the epithelial somitic
bud in the distal-most dermomyotome in the
heterozygote(double arrowheads), while dor-
sal (d) staining in the cytoplasm of myotomal
cells surrounds the b-gal1 nuclei. A continu-
ous intense staining in the neural tube can
also be observed with the Pax-3 probe.
(G±N) Whole-mount in situ hybridizations on
E10.5 wild-type (G, I, K, and M) and Sp homo-
zygous (H, J, L, and N) embryos using anti-
sense MyoD (G and H), myogenin (I and J),
Pax-3 (K and L), and Pax-7 (M and N probes).
The hypoglossal chord (arrow) and forelimb
(fl) labeling is absent in Sp embryos (H and
L), and the ventral and dorsal myotome are
reduced (H and J, opposing arrowheads) as
in (C). Pax-3 expression in somites is more
concentrated in the lateral domain (double
arrowheads).
the patterning of muscle progenitor (b-gal1) cells in Sp/ the lateral edge of interlimb (Figure 4B) and tail (data not
shown) somites. In Sp/Myf-5a21/2 embryos, the myotomeMyf-5a21/2 and Sp/Myf-5a22/2 embryos at an earlier stage.
In normal Myf-5a21/2 embryos, the myotome was well was present; however, a noticeable shortening and dis-
organization of the somiticbud (lateral-most dermomyo-established by E10.5 (Figure 4A) and contained differen-
tiated myocytes expressing skeletal muscle markers. At tome) of interlimb somites as well as a subtle decrease
in size of the medial somitic domain were seen (Figuresthis stage, the dorsal (epaxial) and ventral (hypaxial)
domains of the myotome overlap, rendering this division 4C, 4H, 4J, and 4L; see also Figure 1C).
Notably, in Sp/Myf-5a22/2 double homozygous em-indistinguishable with available muscle markers. In addi-
tion, the forelimbs contain Pax-31 and b-gal1 muscle bryos, b-gal expression was absent in the ventrolateral
aspect of interlimb somites at E10.5 (Figure 4D). In con-precursor cells. In Myf-5a22/2 embryos, the myotome was
absent and muscle progenitor cells were aberrantly trast, b-gal expression was observed in dorsomedial
muscle progenitors, but they appeared disorganizedblocked along the medial edge of all somites and along
Cell
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and slightly more dispersed than in Myf-5a22/2 embryos body on saggital sections of E14.5 double mutant em-
bryos (data not shown). Furthermore, these regions were(compare Figures 4B and 4D). This labeling corre-
sponded to the ectopic b-gal1 cells observed dorsally negative for the early myoblast marker desmin (data not
shown). It is noteworthy that in Sp/Myf-5a22/2 doubleat later stages (Figures 1D, 2H, and 3D). In all mutants
examined, the arches, temporalis, and extraocular mus- homozygous embryos, a few MyoD1 cells that were also
MHC1 were detected in the trunk adjacent to the neuralcles of the head appeared normal (Figures 4A±4D and
data not shown). Thus, Myf-5 activation is independent tube at E12.5 (Figures 3B and 3D). It is not clear whether
these cells originated from the epaxial or hypaxial do-of Pax-3 except in the ventrolateral domain in interlimb
somites (see Discussion). main of the somite. This expression is reminiscent of the
residual myogenin-positive cells observed in the trunkTo determine whether Pax-3 expression is dependent
on Myf-5, we analyzed Myf-5a21/2 and Myf-5a22/2 embryos at E14.5. In addition, neither anti-MyoD nor anti-MHC
(Figure 3D) nor anti-desmin (data not shown) antibodiesby whole-mount in situ hybridization with antisense
Pax-3 combined with X-Gal staining. In normal embryos, marked the ectopically located b-gal1 cells that ap-
peared dorsally, adjacent to the neural tube at this stagePax-3 expression is confined to the somitic bud of the
dermomyotome by E10.5 (Figure 4K). A reactivation of (see also Figure 1D). These findings confirm that the
precursor muscle cell population is almost entirely ab-Pax-3 then occurs in the medial aspect of the myotome
(Figures 4E and 4F and data not shown). As muscle sent in the body of these double homozygous embryos.
progenitor cells leave the lateral dermomyotome to form
the ventral myotome, Pax-3 expression is down-regu-
MyoD Activation Is Delayed in Myf-5 Null Micelated. The activation of Pax-3 was unaffected in the
Since back muscle perturbations were observed inMyf-5 null mutants; however, qualitative differences in
Myf-5 null mice 2 days after the expected activationthe expression pattern were observed in interlimb so-
of MyoD (Figure 1B), we examined the onset of MyoDmites (Figures 4E and 4F). An expanded Pax-3 expres-
expression in normal and Myf-5 null mice, both at thesion pattern laterally corresponds to the aberrant myo-
transcriptional and at the translational level. Interlimbgenic progenitor cell accumulation along this edge of
somites were analyzed to facilitate the simultaneousthe dermomyotome. These b-gal1 muscle progenitor
monitoring of medial and lateral myogenesis and tocells continued to express Myf-5 and Pax-3 (Figures
avoid potential confusion with more anterior shoulder4B, 4E, and 4F and data not shown). In contrast, those
muscles, which do not show the approximately 2-dayleaving the medial somite appeared more dorsally and
delay in activation between Myf-5 and MyoD (Figure 1B).were Pax-3 negative.
MyoD expression appeared relatively synchronouslyThese findings demonstrate that, although qualitative
in the dorsal myotome of all somites at E10 (about 33and quantitative differences in muscle progenitor cell
somites; Figure 4G), whereas earlier expression, atmigrations and patterning were observed in Sp homozy-
E9.75, (about 30 somites) occurred in the ventral myo-gous and Myf-5 null mutants, Pax-3 and Myf-5 genes
tome of interlimb somites, following a rostrocaudal gra-are activated independently of each other. Furthermore,
dient. Transcripts of Myf-5 were also detected in thisPax-3 expression in the somite precedes that of Myf-5;
domain but at considerably lower levels than in the me-it is Myf-5, however, that programs early myogenesis to
dial somite (data not shown). A comparative analysis ofform the myotome.
E10.75 wild-type, heterozygous, and homozygous em-
bryos, stained briefly with X-Gal, revealed that MyoD
transcripts were not detectable in the somites of Myf-5MyoD Is Activated in Body Muscles of Sp
Homozygous but Not Sp/Myf-5 Double null embryos (Figures 5A and 5B) and were present at
a reduced level compared to that in normal embryos atHomozygous Embryos
It is believed that in Myf-5 null mice, Myf-5±independent E11.5 (data not shown). Wild-type and Myf-5a21/2 em-
bryos gave similar intensity staining with the MyoDactivation of MyoD rescues the myogenic program
(Braun et al., 1994) and that either Myf-5 or MyoD is probe (Figure 5A). The whole-mount staining reaction
was stopped prior to saturation of the signal in orderessential for skeletal muscle formation (Rudnicki et al.,
1993). It was therefore important to determine whether to distinguish differences more clearly. Experiments on
non±X-Gal stained embryos gave similar results. TheseMyoD is activated normally in Sp homozygous and Sp/
Myf-5a22/2 double homozygous embryos. Figure 4H results were not dependent on the genetic backgound
of the embryos, since a comparison of embryos ob-shows by whole-mount in situ hybridization that MyoD
transcripts were detectable in all somites of Sp homozy- tained from a mixed genetic background (see Experi-
mental Procedures) with those from outbred mice gavegous embryos at E10.5, the time when MyoD becomes
activated in wild-type embryos (see below). This expres- similar results.
To confirm these findings,we monitoredMyoD proteinsion pattern, which is qualitatively similar to that of myo-
genin (Figures 4H and 4J), reflects the skeletal muscle accumulation. Sections through thoracic somites of
Myf-5a21/2 and Myf-5a22/2 embryos at E11 showed thatperturbations observed in Sp/Myf-5a21/2 embryos at this
stage (see Figure 4C). while most cells expressed both b-gal and MyoD in the
myotome of the Myf-5a21/2 embryo (Figures 5C and 5D),We then examined MyoD expression in Sp/Myf-5a22/2
double homozygous embryos. Figures 3C and 3D show considerably fewer cells expressing MyoD protein were
detected in Myf-5a22/2 embryos (Figure 5F). MHC accu-that MyoD protein was lacking in the trunk and limbs of
these mutants but was present in head muscles (Figures mulation showed a similar delay in Myf-5 null mutants
(data not shown). Therefore, we conclude that there is3E and 3F). MyoD transcripts were not detected in the
Pax-3 and Myf-5 Act Upstream of MyoD
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Figure 5. MyoD Activation Is Delayed in Myf-
5a22/2 Embryos
(A) Wild-type, Myf-5a21/2, and Myf-5a22/2 em-
bryos from E10.75 (39 somite) outbred mice
were stained briefly with X-Gal and then
whole-mount in situ hybridized with an anti-
sense MyoD probe. Both the wild-type and
Myf-5a21/2 embryos reveal MyoD transcript
accumulation in the ventral domain of in-
terlimb somites and dorsally in more anterior
somites.
(B) Enlargement of the interlimb region of the
heterozygous and homozygous mutant em-
bryos in (A). The X-Gal labeling (blue, dorsally,
d) is distinct from the MyoD signal (purple,
ventrally, v; double arrowheads) and distin-
guishes the heterozygous from the homozy-
gous embryo (see also Figures 4A and 4B for
comparison).
(C±F) Transverse cryostat sections in the tho-
racic region of Myf-5a21/2 (C and D) and Myf-
5a22/2 (E and F) E11 (42 somite) embryos re-
acted with both anti-b-gal (red, C and E) and
anti-MyoD (green, D and F) antibodies. As a
control for the anti-MyoD antibody, the man-
dibulararch appearing onthe same section(F)
is MyoD1 (data not shown). b-gal1 and
MyoD1 cells are clearly detectable in the
myotome of the heterozygote (C and D). More
sensitive X-Gal labeling reveals some b-gal1 cells present ventrally (data not shown). In contrast, b-gal1 cells in the homozygote are blocked
dorsally and ventrally (E) and lack MyoD expression (double arrowheads in [F] indicate two MyoD1 cells). Arrows (D) indicate the ven-
tral somitic bud and the dorsal medial lip of the dermomyotome. dmy, dorsal myotome; vmy, ventral myotome; nt, neural tube. Scale bar,
25 mm (C±F).
a delay in MyoD transcript (n 5 5) and protein (n 5 3) (Figure 6). Notably, in Sp homozygous cultures, UPM
yielded strikingly reduced numbers of MyoD1 cells, andaccumulation in Myf-5 null mice, suggesting that initial
MyoD activation is dependent on the prior activation of this continued to be the case in older cultures (data not
shown). In cultures of UPM from Myf-5a22/2 embryos, asMyf-5. Furthermore, this observation reveals that Pax-
3±dependent MyoD activation occurs later than that by expected, the numbers of MyoD1 cells were equivalent
in the presence or absence of axial structures and wereMyf-5.
Unsegmented Paraxial Mesoderm from Sp
Homozygous Embryos Yields Significantly
Reduced Numbers of MyoD-Expressing
Cells in Explant Cultures
We have shown above that the early activation of MyoD
is dependent on the prior activation of Myf-5. To evalute
whether later MyoD activation is dependent on Pax-3,
it was necessary to examine Sp homozygous embryos
in experimental conditions in which the myogenic contri-
bution of Myf-5 would be reduced or eliminated. This
condition can be achieved by using explants of UPM,
cultured in the absence of axial structures (neural tube
and notochord) that normally induce Myf-5 but in the
presence of dorsal ectoderm, which leads to MyoD acti-
vation. After a short period in culture, activation of MyoD
in Myf-51 cells is negligible (Cossu et al., 1996a). We
therefore cultured UPM from E9.5 Sp homozygous em- Figure 6. MyoD Expression Is Significantly Reduced in Explant Cul-
tures of UPM from Sp Homozygous Embryosbryos without axial structures but including dorsal ecto-
derm. The explants were assayed with an anti-MyoD UPM, including dorsal ectoderm, from E9.5 (18±24 somites) Sp het-
erozygous (Sp/1; n 5 5) and Sp homozygous (Sp/Sp; n 5 4) embryosantibody after60 hr inculture. Control cultures consisted
was cultured for 60 hr with or without axial structures (AS; neuralof UPM from Sp homozygous embryos in the presence
tube and notochord). Anti-MyoD antibody staining of cultures per-of axial structures. Explant cultures of Sp heterozygous
mitted MyoD1 cells to be counted. Histograms are presented as a
embryos with and without axial structures served as a percentage of MyoD1 cells in Sp heterozygous cultures with axial
standard for these experiments. As expected, control structures, which gave similar results to wild-type cultures (data not
shown). Error bars, standard error of the mean.cultures showed substantial numbers of MyoD1 cells
Cell
134
probably derived from the lateral part of the dermomyo-
tome and by definition are of hypaxial origin. This raises
the question of whether all hypaxial muscles are ablated
in Sp mice, or whether Pax-3 is required only for the
formation of muscles that necessitate long-range migra-
tions of precursor cells, as our results clearly suggest.
If we now consider perturbations in the somite itself
in Sp mice, the most striking abnormality is the ablation
of the somitic bud, which is derived from the lateral
Figure 7. Model for the Genetic Hierarchies Operating in the Control dermomyotome (see also Bober et al., 1994; Daston
of Skeletal Myogenesis
et al., 1996). The consequence of this perturbation on
Arrows do not necessarily reflect a direct effect; dashed arrow repre-
myotome formation is not clear. In the absence of asents a hypothetical interaction.
specific marker for laterally derived (hypaxial) myogenic
cells, it is difficult todistinguish these cells from medially
derived epaxial muscle that may have expanded later-
significantly higher than with Sp homozygous UPM (data
ally. Nevertheless, it is clear that Sp embryos show per-
not shown). This finding therefore confirms that Pax-3
turbations of myogenic progenitors and the myotome
is required for the activation of the MyoD gene in condi-
laterally. This observation is supported by our experi-
tions in which the Myf-5 contribution is severely re-
ments with explants. In the absence of axial structures
duced. It is noteworthy that MyoD expression was also
(neural tube and notochord), myogenesis by the medial
reduced in Sp homozygous embryos in the presence of
route, which requires Myf-5, is blocked (Cossu et al.,
axial structures. This suggests that Pax-3 as well as
1996b), and lateral myogenic induction by dorsal ecto-
Myf-5 is involved in the activation of MyoD by the axial
derm can be analyzed. We provide evidence that under
structures and is consistent with our in vivo observa-
these conditions, UPM from Sp embryos was severely
tions.
impaired in its ability to produce muscle. This was not
Experiments in which the muscle differentiation
the case when lateral-half somites from Sp embryos
marker MHC was detected with antibodies (data not
were transplanted into the limb bud (Daston et al., 1996);
shown) also clearly indicated that in the absence of axial
however, disruption of somite architecture has been re-
structures, induction of myogenesis by dorsal ectoderm
ported to induce myogenesis (Gamel et al., 1995). In our
is severely impaired in Sp homozygous embryos. These
experiments, we did not distinguish between migratory
findings therefore confirm that in conditions in which
populations and those that will differentiate in the so-
activation via Myf-5 is severely reduced, a Pax-3±
mite. Nevertheless, these observations suggest that lat-
dependent MyoD activation pathway is uncovered.
eral myogenesis by means of signals from the dorsal
ectoderm is mediated mainly through Pax-3 function.
Discussion A second important question is what happens to myo-
genic cells that are derived from the medial dermomyo-
In this study, we used a loss-of-function approach in tome in the absence of Pax-3. Pax-3 is expressed
mice to evaluate the respective roles that the paired throughout the dermomyotome early, and subsequently
box transcription factor Pax-3 and the bHLH myogenic these transcripts are concentrated in the lateral domain
regulatory factors Myf-5 and MyoD play in programming (Williams and Ordahl, 1994; Bober et al., 1994; Goulding
skeletal myogenesis. We demonstrate that muscle pro- et al., 1994). It is therefore very surprising that MyoD
genitor cells in the body require the combined actions activation does not proceed in the Sp/Myf-5a22/2 double
of Pax-3 and Myf-5 to make muscle, while Pax-3 does mutant, as it does in Myf-5 null embryos. In fact, Sp
not appear to play a role in establishing nonsomitic head embryos do show a subtle muscle phenotype in epaxial
muscles. In the absence of these factors, MyoD is not musculature derived from the medial dermomyotome
activated and therefore cannot rescue myogenesis in (see also Franz et al., 1993). The met gene, which ap-
the body, suggesting that MyoD acts genetically down- pears to be a direct downstream target of Pax-3 (Epstein
stream of both Pax-3 and Myf-5 for the establishment et al., 1996; Yang et al., 1996), encodes a tyrosine kinase
of skeletal muscles in the body (Figure 7). receptor that may also play a role in proliferation (Maina
et al., 1996). Notably, met, which is expressed in the
Muscle Progenitor Cell and Skeletal Muscle lateral dermomyotome, where it is necessary for the
Perturbations in Sp Mice migration of cells to the limb (Bladt et al., 1995), is also
By studying heterozygous mice in which the nlacZ re- expressed in the medial lip of the dermomyotome at the
porter gene had been targeted into the Myf-5 locus to time when Pax-3 is down-regulated in this region. Thus,
facilitate the monitoring of muscle development, we at least one downstream gene in the Pax-3 pathway is
confirm and extend previous observations on the Sp expressed in the medial part of the somite when myo-
homozygous mouse. In addition to the absence of limb genesis is taking place.
muscles, some shoulder, ventral body, and tongue mus-
cles are missing (see also Franz et al., 1993; Bober et Pax-3 and Myf-5 Act Genetically Upstream
al., 1994; Goulding et al., 1994). We also show that the of MyoD and Together Are Essential
diaphragm, latissimus dorsi muscle, and muscles of the for Myogenesis in the Body
hypoglossal chord and ventral body wall are ablated Our analysis of Sp/Myf-5a22/2 double homozygous em-
bryos demonstrates that skeletal muscles are absent inin Sp homozygous embryos. All of these muscles are
Pax-3 and Myf-5 Act Upstream of MyoD
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the bodies of these animals. MHC and myogenin, mark- explant experiments MyoD is preferentially activated
(Cossu et al., 1996a). Preferential accumulation of MyoDers of differentiated skeletal muscle, are not expressed,
and furthermore the lack of desmin expression indicates in this domain has also been reported in vivo (Smith et
al., 1994; Patapoutian et al., 1995; Cossu et al., 1996a).that myoblasts are also absent. The trace amount of
differentiated muscle cells that we detect may arise be- Our observations on the Myf-5 null mutant, in which
muscle progenitor cells are blocked in the lateral as wellcause of some leakiness of the Sp allele. Alternatively,
it is possible that mammals have retained a vestige of as themedial domain, also indicates that Myf-5 is indeed
activated laterally. Lateral activation of Myf-5 may repre-a myogenic pathway that escapes theusual early depen-
dence on the MyoD family of myogenic regulators (Smith sent a subpopulation of myogenic precursors. In the
absence of bothPax-3 and Myf-5, this lateral expressionet al., 1993). In Drosophila, a significant proportion of
myogenic cells do not depend on the single D-MyoD is ablated, suggesting that Pax-3 is acting upstream of
Myf-5 in this region of the embryo.(nautilus) gene (Bate, 1992).
In contrast to the body, nonsomitic head muscles are
present in the double mutant; MyoD is activated and How Do Pax-3 and Myf-5 Control Myogenesis?
In vitro experiments have shown that overexpression ofother muscle markers accumulate as expected, raising
the possibility that Pax-3 plays a key regulatory role in Myf-5 in a non±muscle cell results in MyoD activation
(Weintraub et al., 1991). A simple explanation for thesomitic mesoderm and not in more anterior paraxial and
prechordal mesoderm, from which the majority of head lack of MyoD in the Sp/Myf-5a22/2 double mutant is that
MyoD is also transcriptionally activated by Pax-3. Themuscles arise. A subset of tongue muscles are derived
from the somites, and Sp homozygous mice have de- explant experiments reported here suggest this. In keep-
ing with this interpretation, in explant experiments withfects in tongue muscle development. In addition, we
find that a group of neck muscles that extend from the presomitic mesoderm, dorsal ectoderm activates Pax-3
(Fan and Tessier-Lavigne, 1994) as well as MyoD (Cossuhead into the body are present in the double mutant.
The mesodermal origin of the latter is not clear. A more et al., 1996a). Furthermore, experiments with ectopically
expressed Pax-3 suggest that this may be the casedetailed analysis of these and other head muscles
should help to determine whether Pax-3 function is in- (Maroto et al., 1997 [this issue of Cell]).
Other aspectsof Pax-3 function have to beconsidereddeed limited to somitic mesoderm. In support of this,
we detect neither Pax-3 nor Pax-7 expression (see also in this context. Pax-3 has been reported to inhibit myo-
genic differentiation under some conditions (Epstein etMansouri et al., 1996) in head muscles or their pre-
cursors. al., 1995), and this may be related to the fact that overex-
pression of Pax genes, either in vitro or as a result of
a chromosomal rearrangement, transforms certain cell
MyoD Activation Is Dependent lines (Tremblay and Gruss, 1994). Since the met gene
on Both Pax-3 and Myf-5 is expressed in the medial part of the dermomyotome
Previous analysis of the Myf-5 null mutant showed that after Pax-3 has been down-regulated in this part of the
MyoD rescues muscle development (Braun et al., 1992). somite (Yang et al., 1996), it is possible that Pax-3, per-
Based on that finding and the report that MyoD activa- haps through Met, is necessary for the amplification of
tion takes place normally in Myf-5 null mice (Braun et a population of myogenic progenitor cells that subse-
al., 1994), it has been concluded that MyoD activation quently express MyoD. Similarly, ablation of the lateral
is independent of Myf-5. Therefore, given the phenotype dermomyotome in Sp embryos, with loss of the somitic
of the Sp/Myf-5a22/2 double homozygous embryos, it bud, may also point to the loss of a reservoir of Pax-31
might be expected that MyoD activation is Pax-3, not stem cells that would normally feed into the postmitotic
Myf-5, dependent. However, we show that in Myf-5 null myotome (Figure 5D).
embryos, MyoD activation is delayed. The discrepancy Pax-3 is clearly involved in long-range cell migrations,
between our results and those reported previously probably by means of the Met receptor and its ligand,
(Braun et al., 1994), at least with regard to cranial so- scatter factor (Bladt et al., 1995). It may also be critical
mites, may be explained by the presence of a group of for short-range migration within the somite. Again, the
shoulder muscles anterior to the forelimb that do not expression of the Met receptor in the medial as well
show the usual delay between Myf-5 and MyoD activa- as lateral domain of the dermomyotome and in body
tion; the development of these muscles is not perturbed muscles that are probably of epaxial origin (Sonnenberg
in Myf-5a22/2 embryos. Our comparative analysis be- et al., 1993; Yang et al., 1996) is consistent with a role
tween control and Myf-5a22/2 embryos clearly demon- in short-range migration. In the head, muscle positioning
strates an initial dependence of MyoD activation on as a result of growth rather than extensive cell migration
Myf-5 at most sites in the trunk of the embryo. It has may obviate the need for Pax-3, or alternatively, another
been proposed, based on experiments with ES cells, gene functionally substitutes for Pax-3 in the head.
that MyoD and Myf-5 are activated in independent cell From our analysis of the Myf-5a22/2 null embryos, we
lineages and are not coexpressed (Braun and Arnold, have demonstrated that in the absence of this myogenic
1996). Our observations on Myf-5a21/2 embryos and with factor, muscle progenitor cells migrate aberrantly and
explants show that MyoD is activated in medially derived fail to localize to the cental aspect of the somite. We
muscle cells that have already activated Myf-5 (Cossu suggested that Myf-5 may ªdetermineº the fate of myo-
et al., 1996a; Tajbakhsh et al., 1996a). genic progenitor cells by activating a cell surface com-
Unexpectedly, the delay in MyoD activation is also ponent that permits them to respond correctly to posi-
tional cues in the embryo; in the absence of Myf-5, theevident in the lateral aspect of the somite, where in
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2 days with changes of the solution (alkaline phosphatase substrate,cells do not enter an environment that permits myogen-
Boehringer). In some cases, embryos were stained briefly with X-Galesis to take place (Tajbakhsh et al., 1996b). Pax-3 may
(Tajbakhsh and Buckingham, 1994) prior to hybridization. Antisenseplay a similar role. However, the inactivation of Myf-5,
probes used during this study were MyoD and myogenin (Sassoon
in contrast to that of Pax-3, does not appear to interfere et al., 1989), Pax-3 (519 bp PstI/HindIII fragment from the 39 end of
with the elaboration of this muscle progenitor cell popu- cDNA), and Pax-7 (Jostes et al., 1990; kindly provided by P. Gruss).
Slides were processed for autoradiography, developed after 8±10lation or with their delamination from the dermomyo-
days, and photographed with a Zeiss Axiophot microscope. Photo-tome (Tajbakhsh et al., 1996b). To evaluate the precise
graphs of whole-mount stained embryos were taken with an Olym-role that Pax-3 plays in myogenesis, it will be important
pus SZH10 stereomicroscope.to see whether met2/2/Myf-5a22/2 double null mice have
the same phenotype as Sp/Myf-5a22/2 double mutants.
Explant Cultures and ImmunofluorescenceWe have initiated experiments of this kind to investigate
E9.5 embryos were dissected at room temperature in RPMI (GIBCO±
the respective roles of Pax-3 and Myf-5, which, in the BRL) medium, and the UPM with dorsal ectoderm but without most
genetic hierarchy established in our study (Figure 7), act of the lateral mesoderm was removed from wild-type, heterozygous,
upstream of MyoD in the initiation of myogenesis. and homozygous embryos. At this stage, the UPM would give rise
to somites of the interlimb region. The remainder of the embryo was
used for genotyping. Axial structures were dissected away from
Experimental Procedures somites using 0.1% pancreatin and 0.1% trypsin for 2 min at 48C,
and the reaction was stopped with the addition of medium con-
Generation of Embryos and Genotyping taining serum. Individual explants were grown on a feeder layer of
Gene targeting of the Myf-5 locus with the nlacZ (n, nuclear localiza- 10T1/2 cells in RPMI supplemented with 10% decomplemented
tion signal) reporter gene has been described previously (Tajbakhsh (568C, 30 min) fetal calf serum. Immunofluorescence was carried
et al., 1996b). Heterozygous Myf-5a21/2 (129sv/C57BL6/DBA2) and out (Tajbakhsh and Buckingham, 1995; Cossu et al., 1996a) with the
Sp (C57BL6, Jackson Laboratories) mice were interbred to obtain following: a polyclonal anti-MyoD (a gift from J. Harris), monoclonal
double heterozygous animals. Sp /1/Myf-5a21/2 mice were then in- anti-MHC MF20 antibody, anti-MHC (polyclonal), and anti-b-gal
terbred to obtain Sp/Myf-5a22/2 double homozygous embryos. Mice (monoclonal, Sigma). Secondary antibodies were conjugated with
carrying the Myf-5a2 mutation were also analyzed on an outbred Texas-Red (Amersham; Figure 3), rhodamine (Sigma; Figure 5), or
(CD1) genetic background. To distinguish Myf-5 mutant embryos in peroxidase (Sigma). MyoD1 cells were scored per explant experi-
the litter, genotyping by polymerase chain reaction (PCR) of yolk ment after 60 hr. Cell survival, as evaluated by Hoechst 33258 stain-
sacs or a portion of the embryo was used to detect the wild-type ing, appeared similar in Sp heterozygous and homozygous embryo
(225 bp), heterozygous (225 and 414 bp), and homozygous (414 bp) cultures.
alleles as described previously (Picard, 1994). A combination of
three oligonucleotides was used: M5KO1, 59-GGT GTC TCC TCT
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